Mercury Bio Appoints Casey Perkins as New Chief Business Officer Driving Biotech Innovation#United_States#biotechnology#Santa_Fe,_New_Mexico#Mercury_Bio#Casey_Perkins
Mercury Bio Appoints Casey Perkins as New Chief Business Officer Driving Biotech Innovation
Mercury Bio announces the promotion of Casey Perkins to Chief Business Officer. Her leadership in biotech will drive advances in neurodegenerative disease research.
third-news.com
June 23, 2026 at 1:55 PM
Mercury Bio Appoints Casey Perkins as New Chief Business Officer Driving Biotech Innovation#United_States#biotechnology#Santa_Fe,_New_Mexico#Mercury_Bio#Casey_Perkins
Mercury Bio Introduces MB-TIP™: A New Era in Immunotherapy for Neurodegenerative Diseases#United_States#Immunotherapy#Santa_Fe,_New_Mexico#Mercury_Bio#MB-TIP
Mercury Bio Introduces MB-TIP™: A New Era in Immunotherapy for Neurodegenerative Diseases
Mercury Bio has unveiled MB-TIP™, an innovative platform utilizing exosome technology to deliver therapies for Alzheimer's and Parkinson's directly to affected cells. This groundbreaking approach could significantly advance immunotherapy.
third-news.com
January 8, 2026 at 1:57 PM
Mercury Bio Introduces MB-TIP™: A New Era in Immunotherapy for Neurodegenerative Diseases#United_States#Immunotherapy#Santa_Fe,_New_Mexico#Mercury_Bio#MB-TIP
Mercury Bio and Meta-Flux Forge Alliance to Combat Neurodegenerative Diseases#United_States#Santa_Fe#Neurodegenerative#Mercury_Bio#Meta-Flux
Mercury Bio and Meta-Flux Forge Alliance to Combat Neurodegenerative Diseases
Mercury Bio and Meta-Flux have partnered to enhance therapeutics for Parkinson's and Alzheimer's diseases, utilizing AI and innovative technology.
third-news.com
December 19, 2025 at 1:57 PM
Mercury Bio and Meta-Flux Forge Alliance to Combat Neurodegenerative Diseases#United_States#Santa_Fe#Neurodegenerative#Mercury_Bio#Meta-Flux
Mercury Bio Welcomes Casey Perkins as VP to Propel Corporate Strategy and Business Development#USA#Santa_Fe#Mercury_Bio#Casey_Perkins#yEV_platform
Mercury Bio Welcomes Casey Perkins as VP to Propel Corporate Strategy and Business Development
Mercury Bio has appointed Casey Perkins as the new Vice President of Corporate Strategy & Business Development, aiming to enhance its drug delivery platform's reach and efficacy.
third-news.com
December 9, 2025 at 2:42 PM
Mercury Bio Welcomes Casey Perkins as VP to Propel Corporate Strategy and Business Development#USA#Santa_Fe#Mercury_Bio#Casey_Perkins#yEV_platform
Mercury Bio's Breakthrough Preclinical Study Focuses on Innovative Drug Delivery to the Brain#United_States#Santa_Fe#Brain_Delivery#Mercury_Bio#yEV
Mercury Bio's Breakthrough Preclinical Study Focuses on Innovative Drug Delivery to the Brain
Mercury Bio celebrates promising results from a preclinical study showcasing their novel protein delivery technology targeting the brain, enhancing treatment potentials.
third-news.com
October 1, 2025 at 2:07 PM
Mercury Bio's Breakthrough Preclinical Study Focuses on Innovative Drug Delivery to the Brain#United_States#Santa_Fe#Brain_Delivery#Mercury_Bio#yEV
Frame Bio Secures Licensing for Innovative Drug Delivery Technology to Aid Regenerative Medicine#United_States#Santa_Fe#Drug_Delivery#Frame_Bio#Mercury_Bio
Frame Bio Secures Licensing for Innovative Drug Delivery Technology to Aid Regenerative Medicine
Frame Bio has announced a strategic licensing agreement with Mercury Bio, gaining access to novel drug delivery technology aimed at treating bone and collagen disorders effectively.
third-news.com
September 17, 2025 at 1:19 PM
Frame Bio Secures Licensing for Innovative Drug Delivery Technology to Aid Regenerative Medicine#United_States#Santa_Fe#Drug_Delivery#Frame_Bio#Mercury_Bio